Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001974158-23-000036
Filing Date
2023-07-07
Accepted
2023-07-07 13:07:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 22605
  Complete submission text file 0001974158-23-000036.txt   24189
Mailing Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024
Business Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024 (858) 945-2393
Ventyx Biosciences, Inc. (Subject) CIK: 0001851194 (see all company filings)

EIN.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40928 | Film No.: 231076130
SIC: 2834 Pharmaceutical Preparations

Mailing Address 500 WEST PUTNAM AVE SUITE 400 GREENWICH CT 06830
Business Address 500 WEST PUTNAM AVE SUITE 400 GREENWICH CT 06830 2126885100
NSV Partners III LP (Reporting) CIK: 0001890004 (see all company filings)

EIN.: 371941525 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144